Challenges and Opportunities in Developing an Oncology Clinical Trial Network in the United States Veterans Affairs Health Care System: The VA STARPORT Experience. Curr Oncol 2024 Aug 21;31(8):4781-4794
Date
08/28/2024Pubmed ID
39195341Pubmed Central ID
PMC11353739DOI
10.3390/curroncol31080358Scopus ID
2-s2.0-85202618048 (requires institutional sign-in at Scopus site)Abstract
The United States Veterans Affairs (VA) Health Care System has a strong history of conducting impactful oncology randomized clinical trials (RCTs). We developed a phase II/III RCT to test the use of metastasis-directed therapy in Veterans with oligometastatic prostate cancer (OMPC)-the first VA RCT in OMPC that leverages novel imaging and advanced radiotherapy techniques. To accomplish this, we developed a clinical trial network to conduct the study. In this manuscript, we describe several challenges we encountered in study development/conduct and our strategies to address them, with the goal of helping investigators establish robust study networks to conduct clinical trials. In the study start-up, we encountered challenges in timely site activation, and leveraged project management to maximize efficiency. Additionally, there were several changes in the clinical paradigms in imaging and treatment that led to protocol amendments to ensure maximum equipoise, recruitment, and impact of the study. Specifically, we amended the trial to add de novo OMPC patients (from initially only recurrent OMPC) and expanded the study to allow up to 10 metastases (from initially five). Finally, in order to maintain local study team engagement, we developed initiatives to maximize collaboration and add value to the overall clinical program through study participation.
Author List
Solanki AA, Zheng K, Skipworth AN, Robin LM, Leparski RF, Henry E, Rettig M, Salama JK, Ritter T, Jones J, Quek M, Chang M, Block AM, Welsh JS, Kumar A, Chao HH, Chen AC, Shapiro R, Bitting RL, Kwon R, Stross W, Puckett L, Wong YN, Nickols NG, Carlson K, VA STARPORT Investigators GroupAuthor
Lindsay L. Puckett MD Associate Professor in the Radiation Oncology department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Clinical Trials as TopicHumans
Male
Medical Oncology
Prostatic Neoplasms
United States
United States Department of Veterans Affairs
Veterans